170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
Latest Articles
Surprise discovery redirects efforts for treatment of liver disease

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li

Surprise discovery redirects efforts for treatment of liver disease

by Walter and Eliza Hall Institute of Medical ResearchGraphical abstract. Credit:Gastroenterology(2022). DOI: 10.1053/j.gastro.2022.08.040WEHI researchers have revealed that common li
Scientists find omega-3 lysolipids may prevent fatty liver disease

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by
CDC: Prevalence of any past, present hep B infection 4.3 percent

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers
Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you
Study finds cirrhosis affects twice as many transgender adults as cisgender adults

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that
Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).

Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model

by Sichuan International Medical Exchange and Promotion AssociationPrevalence of minimal hepatic encephalopathy (MHE) in different groups of patients with cirrhosis. Credit:MedComm(2024).
Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi
Acute pancreatitis and the rise of alcohol-related deaths

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with

Acute pancreatitis and the rise of alcohol-related deaths

by Deb Balzer,Mayo ClinicEndoscopic retrograde cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts and pancreatic duct on X-ray images. A thin, flexible tube (endoscope) with
Hepatitis B: 'Sleep timer' for immune cells discovered

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l

Hepatitis B: 'Sleep timer' for immune cells discovered

byTechnical University MunichA virus-specific T cell (blue) in the vascular system of a liver with chronic hepatitis B virus infection. Credit: Percy A. Knolle / TUMIn chronic hepatitis B, the l
Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:

Reviewing metabolic dysfunction-associated fatty liver disease opens new treatment pathways

by First Hospital of Jilin UniversityRisk of incident CKD in MAFLD: sensitivity analysis. (A) Risk of incident CKD in MAFLD: sensitivity analysis in cohort studies. (B) Risk of prevalent CKD in MAFLD:
Universal gut microbiome-derived signature predicts cirrhosis

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic

Universal gut microbiome-derived signature predicts cirrhosis

by University of California - San DiegoIllustration depicts a healthy liver (left) and a liver with cirrhosis. Credit: National Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic
Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi

Liver Cancer Facts and Statistics: What You Need to Know

Liver Cancer Facts and Statistics: What You Need to KnowLiver cancer is the fifth-deadliest cancer for malesByJennifer WelshPublished on July 25, 2022Medically reviewed byKashi